Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
A stem cell therapy trial aimed at reducing neuroinflammation in patients with presymptomatic Alzheimer's disease is underway at UTHealth Houston.
National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...
ARC101, a potential best-in-class T-cell engager that targets solid tumors expressing CLDN6, is being assessed in a ...
Clinical Trials Arena on MSN1d
BioCity and MSD to evaluate cancer treatment combination in Phase I/II trialBioCity Biopharmaceuticals and MSD have signed a clinical trial partnership agreement to assess BC3195 in conjunction with ...
For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...
Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...
Software-based quantitative assessment of ablation margins: a new standard for liver tumour ablation
For a long time, thermal ablation was considered an alternative to surgical resection for patients with malignant liver tumours. However, it should now be regarded as the preferred treatment for ...
Sutro Biopharma, Inc.’s STRO share price has dipped by 35.19%, which has investors questioning if this is right time to buy.
We recently published a list of 12 Best Multibagger Stocks to Buy in 2025. In this article, we are going to take a look at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback